Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy

Acta Biomaterialia

Volumn 14, Issue , 2015, Pages 61-69

  Jiang, Chenxiao ^a   Cheng, Hao ^a   Yuan, Ahu ^a   Tang, Xiaolei ^a   Wu, Jinhui ^a   Hu, Yiqiao ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Antitumor therapy; Drug delivery; NIR dye; Solubilization

Indexed keywords

BODY FLUIDS; DRUG DELIVERY; HYDROPHOBICITY; INFRARED DEVICES; MEDICAL IMAGING; NANOPARTICLES; PHOTODYNAMIC THERAPY; SELF ASSEMBLY; TOXICITY; TUMORS;

ALBUMIN NANOPARTICLES; ANTI-TUMORS; ANTITUMOR THERAPY; HUMAN SERUM ALBUMINS; HYDROPHOBICS; NEAR-INFRARED DYES; NIR DYES; PHOTO-THERMAL; PHOTOTHERMAL THERAPY; SOLUBILISATION;

SOLUBILITY;

HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMIN IR 780 IODIDE NANOPARTICLE; IODIDE; NANOPARTICLE; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 2-(2-(2-CHLORO-3-((1,3-DIHYDRO-3,3-DIMETHYL-1-PROPYL-2H-INDOL-2-YLIDENE)ETHYLIDENE)-1-CYCLOHEXEN-1-YL)ETHENYL)-3,3-DIMETHYL-1-PROPYLINDOLIUM; INDOLE DERIVATIVE; SERUM ALBUMIN; SOLUTION AND SOLUBILITY;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; DISULFIDE BOND; DRUG EFFICACY; DRUG HYDROLYSIS; DRUG SAFETY; DRUG SOLUBILITY; DRUG STABILITY; DRUG TOXICITY; FLUORESCENCE IMAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NANOENCAPSULATION; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PRIORITY JOURNAL; TUMOR VOLUME; ULTRAFILTRATION; ANIMAL; BAGG ALBINO MOUSE; CELL DEATH; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; HUMAN; HYPERTHERMIC THERAPY; LIGHT RELATED PHENOMENA; MCF 7 CELL LINE; METABOLISM; SOLUTION AND SOLUBILITY; SYNTHESIS; TREATMENT OUTCOME; ULTRASTRUCTURE;

MUS;

ANIMALS; CELL DEATH; CELL SURVIVAL; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPERTHERMIA, INDUCED; INDOLES; MALE; MCF-7 CELLS; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; NANOPARTICLES; OPTICAL PHENOMENA; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN; SOLUTIONS; SPECTROSCOPY, NEAR-INFRARED; TREATMENT OUTCOME;

EID: 84921830340     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.11.041     Document Type: Article

References (20)

1. Yuan A, Wu J, Tang X, Zhao L, Xu F, Hu Y. Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies. J Pharm Sci 2013;102:6-28.
2. Zhang C, Wang S, Xiao J, Tan X, Zhu Y, Su Y, et al. Sentinel lymph node mapping by a near-infrared fluorescent heptamethine dye. Biomaterials 2010;31:1911-7.
3. Wilk KA, Zielinska K, Pietkiewicz J, Skolucka N, Choromanska A, Rossowska J, et al. Photo-oxidative action in MCF-7 cancer cells induced by hydrophobic cyanines loaded in biodegradable microemulsion-templated nanocapsules. Int J Oncol 2012;41:105-16.
4. Tan X, Luo S, Wang D, Su Y, Cheng T, Shi C. A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties. Biomaterials 2012;33:2230-9.
5. Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials 2011;32:7127-38.
6. Yue C, Liu P, Zheng M, Zhao P, Wang Y, Ma Y, et al. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials 2013;34:6853-61.
7. Zhang C, Liu T, Su Y, Luo S, Zhu Y, Tan X, et al. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials 2010;31:6612-7.
8. Peng CL, Shih YH, Lee PC, Hsieh TM, Luo TY, Shieh MJ. Multimodal image-guided photothermal therapy mediated by 188Re-labeled micelles containing a cyanine-type photosensitizer. ACS Nano 2011;5:5594-607.
9. Singh AK, Hahn MA, Gutwein LG, Rule MC, Knapik JA, Moudgil BM, et al. Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy. Int J Nanomed 2012;7:2739-50.
10. Gong G, Xu Y, Zhou Y, Meng Z, Ren G, Zhao Y, et al. Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image. Biomacromolecules 2012;13:23-8.
11. Wu J, Song C, Jiang C, Shen X, Qiao Q, Hu Y. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery. Mol Pharm 2013;10:3555-63.
12. Ding D, Tang X, Cao X, Wu J, Yuan A, Qiao Q, et al. Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy. AAPS PharmSciTech 2014;15:213-22.
13. Ragas X, Jimenez-Banzo A, Sanchez-Garcia D, Batllori X, Nonell S. Singlet oxygen photosensitisation by the fluorescent probe Singlet Oxygen Sensor Green. Chem Commun (Camb) 2009:2920-2.
14. Gollmer A, Arnbjerg J, Blaikie FH, Pedersen BW, Breitenbach T, Daasbjerg K, et al. Singlet Oxygen Sensor Green®: photochemical behavior in solution and in a mammalian cell. Photochem Photobiol 2011;87:671-9.
15. Chen R, Wang X, Yao X, Zheng X, Wang J, Jiang X. Near-IR-triggered photothermal/photodynamic dual-modality therapy system via chitosan hybrid nanospheres. Biomaterials 2013;34:8314-22.
16. Peng J, Zhao L, Zhu X, Sun Y, Feng W, Gao Y, et al. Hollow silica nanoparticles loaded with hydrophobic phthalocyanine for near-infrared photodynamic and photothermal combination therapy. Biomaterials 2013;34:7905-12.
17. Chauhan VP, Stylianopoulos T, Martin JD, Popovic Z, Chen O, Kamoun WS, et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol 2012;7:383-8.
18. Celgene. Abraxane® for injectable suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). US Food and Drug Administration; 2005.
19. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82.
20. Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310-6.